You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Studies Phase 2 and 3 Clinical Trial of Oral Bexarotene (Targretin Capsules) for the Treatment of Refractory or Persistent Early-Stage Cutaneous T-Cell Lymphoma
Madeleine Duvic; Ann G. Martin; Youn Kim; Elise Olsen; Gary S. Wood; Constance A. Crowley; Richard C. Yocum; for the Worldwide Bexarotene Study Group
Arch Dermatol 2001; 137: 581-593.
[Abstract][Full text][PDF]
Observations Cutaneous Adverse Reactions to Hydroxyurea in Patients With Sickle Cell Disease
Observations Drug-Induced Lupus Associated With COL-3: Report of 3 Cases
Jayashri V. Ghate; Maria L. Turner; Michelle A. Rudek; William D. Figg; William Dahut; Valerie Dyer; James M. Pluda; Eddie Reed
Arch Dermatol 2001; 137: 471-474.
[Abstract][Full text][PDF]
Reviews Suggested Rationale for Prevention and Treatment of Glucocorticoid-Induced Bone Loss in Dermatologic Patients
Gil Yosipovitch; Tan Suat Hoon; Goh Chee Leok
Arch Dermatol 2001; 137: 477-481.
[Abstract][Full text][PDF]